Jurors in the penalty trial of Florida school shooter Nikolas Cruz arrived for their second day of deliberations Thursday to examine the gun he used to murder 17 people at Parkland's Marjory Stoneman Douglas High School four years ago.
The panel of 12 people had asked late Wednesday to see the AR-15-style semi-automatic rifle, but the Broward County Sheriff's Office security team objected, even though the gun has been made inoperable and Cruz's ammunition would be removed from the jury room.
Lead prosecutor Mike Satz, who has more the five decades of experience, pointed out that in every murder case he has tried or knows, jurors got to examine and handle the weapon in their room — and he said a knife or machete is more dangerous than a gun without a firing pin. Security has never been an issue, he said.
Cruz's attorneys had no objection to jurors seeing the gun.
Cruz, 24, pleaded guilty a year ago to murdering 14 students and three staff members and wounding 17 others on Feb. 14, 2018. Cruz said he chose Valentine’s Day to make it impossible for Stoneman Douglas students to celebrate the holiday ever again. The jury will determine only if Cruz is sentenced to death or life without parole. For Cruz to get a death sentence, the jury must be unanimous.
During the prosecution's rebuttal case, Satz and his team argued that Cruz's smooth movements with the gun and his ease in reloading helps show he does not have any neurological disorders, as claimed by his attorneys.
Lead defense attorney Melisa McNeill and her team have never disputed that Cruz committed a horrible crime, but they say his birth mother's excessive drinking during pregnancy left him with fetal alcohol spectrum disorder and put him on a path that led to the shooting.
The massacre is the deadliest mass shooting that has ever gone to trial in the U.S. Nine other people in the U.S. who fatally shot at least 17 people died during or immediately after their attacks by suicide or police gunfire. The suspect in the 2019 massacre of 23 at an E l Paso, Texas, Walmart is awaiting trial.